<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="697">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05152082</url>
  </required_header>
  <id_info>
    <org_study_id>2021-SR-365</org_study_id>
    <nct_id>NCT05152082</nct_id>
  </id_info>
  <brief_title>Establishment and Validation of a Predictive Model for the Risk of Colorectal Advanced Adenomas</brief_title>
  <official_title>Establishment and Validation of a Predictive Model for the Risk of Colorectal Advanced Adenomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital with Nanjing Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to analyze the risk factors of colorectal advanced adenoma and constructe a&#xD;
      model to predict the high-risk individuals of harbouring colorectal advanced adenomas, so as&#xD;
      to better identify screening participants and provide an important theoretical basis for the&#xD;
      prevention of colorectal cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A large cohort of eligible patients were included in the analysis, and classified into&#xD;
      derivation and validation cohorts at a ratio of 7:3. Demographic and clinicopathological&#xD;
      characteristics of participants were utilized to develop a prediction model for colorectal&#xD;
      advanced polyps. In the derivation cohort, the LASSO regression method was applied to filter&#xD;
      variables and multivariate logistic regression analysis was used to identify important&#xD;
      predictors.A prediction model was established based on the results of multivariate logistic&#xD;
      regression analysis. The predictive performance of the model was evaluated with respect to&#xD;
      its discrimination, calibration and clinical usefulness.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Demographic characteristics of patients with colorectal adenomas checklist</measure>
    <time_frame>1 year</time_frame>
    <description>Age (years), sex (man/woman), family history of colorectal cancer (in first-degree relatives, including parents and siblings), history of smoking (never, past, current), history of alcohol consumption (never, past, current), regular use of non-steroidal anti-inflammatory drugs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>weight (kilograms)</measure>
    <time_frame>1 year</time_frame>
    <description>Clinicopathological characteristics of patients with colorectal adenomas</description>
  </primary_outcome>
  <primary_outcome>
    <measure>height (meters)</measure>
    <time_frame>1 year</time_frame>
    <description>Clinicopathological characteristics of patients with colorectal adenomas</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The important high-risk factors of colorectal advanced adenoma</measure>
    <time_frame>1 year</time_frame>
    <description>The important high-risk factors with p value &lt; 0.05</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Colorectal Adenoma</condition>
  <arm_group>
    <arm_group_label>patients with colorectal advanced adenomas</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>patients without colorectal advanced adenomas</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Confirmed eligible patients, 18 to 75 years of age, including cases with colorectal&#xD;
        advanced adenomas and controls without colorectal advanced adenomas, are enrolled in this&#xD;
        study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged ≥18 and ≤75 years old. Patients with complete data on demography and&#xD;
             clinicopathology.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a history of inflammatory bowel disease, enterophthisis, familial&#xD;
             adenomatous polyposis, P-J syndrome and intestinal lymphoma.&#xD;
&#xD;
        Patients with a previous history of colorectal neoplasm. Patients with a history of severe&#xD;
        systemic diseases. Lack of complete clinical data for analysis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hong Zhu, MD</last_name>
    <email>zhuhong1059@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital with Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Zhu, MD</last_name>
      <email>zhuhong1059@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Betés M, Muñoz-Navas MA, Duque JM, Angós R, Macías E, Súbtil JC, Herraiz M, De La Riva S, Delgado-Rodríguez M, Martínez-González MA. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003 Dec;98(12):2648-54.</citation>
    <PMID>14687811</PMID>
  </reference>
  <reference>
    <citation>Wong MC, Lam TY, Tsoi KK, Hirai HW, Chan VC, Ching JY, Chan FK, Sung JJ. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 2014 Jul;63(7):1130-6. doi: 10.1136/gutjnl-2013-305639. Epub 2013 Sep 17.</citation>
    <PMID>24045331</PMID>
  </reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 8, 2021</study_first_submitted>
  <study_first_submitted_qc>December 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>December 5, 2021</last_update_submitted>
  <last_update_submitted_qc>December 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

